Skip to main content
Erschienen in: Heart and Vessels 11/2017

19.06.2017 | Original Article

Noninvasive evaluation of reverse atrial remodeling after catheter ablation of atrial fibrillation by P wave dispersion

verfasst von: Yuhi Fujimoto, Kenji Yodogawa, Kenta Takahashi, Ippei Tsuboi, Hiroshi Hayashi, Shunsuke Uetake, Yu-ki Iwasaki, Meiso Hayashi, Yasushi Miyauchi, Wataru Shimizu

Erschienen in: Heart and Vessels | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Atrial fibrillation (AF) itself creates structural and electrophysiological changes such as atrial enlargement, shortening of refractory period and decrease in conduction velocity, called “atrial remodeling”, promoting its persistence. Although the remodeling process is considered to be reversible, it has not been elucidated in detail. The aim of this study was to assess the feasibility of P wave dispersion in the assessment of reverse atrial remodeling following catheter ablation of AF. Consecutive 126 patients (88 males, age 63.0 ± 10.4 years) who underwent catheter ablation for paroxysmal AF were investigated. P wave dispersion was calculated from the 12 lead ECG before, 1 day, 1 month, 3 months and 6 months after the procedure. Left atrial diameter (LAD), left atrial volume index (LAVI), left ventricular ejection fraction (LVEF), transmitral flow velocity waveform (E/A), and tissue Doppler (E/e′) on echocardiography, plasma B-type natriuretic peptide (BNP) concentrations, serum creatinine, and estimated glomerular filtration rate (eGFR) were also measured. Of all patients, 103 subjects remained free of AF for 1 year follow-up. In these patients, P wave dispersion was not changed 1 day and 1 month after the procedure. However, it was significantly decreased at 3 and 6 months (50.1 ± 14.8 to 45.4 ± 14.4 ms, p < 0.05, 45.2 ± 9.9 ms, p < 0.05, respectively). Plasma BNP concentrations, LAD and LAVI were decreased (81.1 ± 103.8 to 44.8 ± 38.3 pg/mL, p < 0.05, 38.2 ± 5.7 to 35.9 ± 5.6 mm, p < 0.05, 33.3 ± 14.2 to 29.3 ± 12.3 mL/m2, p < 0.05) at 6 months after the procedure. There were no significant changes in LVEF, E/A, E/e′, serum creatinine, and eGFR during the follow up period. P wave dispersion was decreased at 3 and 6 months after catheter ablation in patients without recurrence of AF. P wave dispersion is useful for assessment of reverse remodeling after catheter ablation of AF.
Literatur
1.
Zurück zum Zitat Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954–1968CrossRefPubMed Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954–1968CrossRefPubMed
2.
Zurück zum Zitat Morillo CA, Klein GJ, Jones DL, Guiraudon CM (1995) Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 91:1588–1595CrossRefPubMed Morillo CA, Klein GJ, Jones DL, Guiraudon CM (1995) Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 91:1588–1595CrossRefPubMed
3.
Zurück zum Zitat Therkelsen SK, Groenning BA, Svendsen JH, Jensen GB (2006) Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion. Am J Cardiol 97:1213–1219CrossRefPubMed Therkelsen SK, Groenning BA, Svendsen JH, Jensen GB (2006) Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion. Am J Cardiol 97:1213–1219CrossRefPubMed
4.
Zurück zum Zitat Thomas L, Boyd A, Thomas SP, Schiller NB, Ross DL (2003) Atrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation. Eur Heart J 24:1942–1951CrossRefPubMed Thomas L, Boyd A, Thomas SP, Schiller NB, Ross DL (2003) Atrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation. Eur Heart J 24:1942–1951CrossRefPubMed
5.
Zurück zum Zitat Choi JI, Park SM, Park JS, Hong SJ, Pak HN, Lim do S, Kim YH, Shim WJ (2008) Changes in left atrial structure and function after catheter ablation and electrical cardioversion for atrial fibrillation. Circ J 72:2051–2057CrossRefPubMed Choi JI, Park SM, Park JS, Hong SJ, Pak HN, Lim do S, Kim YH, Shim WJ (2008) Changes in left atrial structure and function after catheter ablation and electrical cardioversion for atrial fibrillation. Circ J 72:2051–2057CrossRefPubMed
6.
Zurück zum Zitat Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, Toutouzas PK (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135:733–738CrossRefPubMed Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, Toutouzas PK (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135:733–738CrossRefPubMed
7.
Zurück zum Zitat Aytemir K, Ozer N, Atalar E, Sade E, Aksöyek S, Ovünç K, Oto A, Ozmen F, Kes S (2000) P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23:1109–1112CrossRefPubMed Aytemir K, Ozer N, Atalar E, Sade E, Aksöyek S, Ovünç K, Oto A, Ozmen F, Kes S (2000) P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23:1109–1112CrossRefPubMed
8.
Zurück zum Zitat Ozer N, Aytemir K, Atalar E, Sade E, Aksöyek S, Ovünç K, Açýl T, Nazlý N, Ozmen F, Oto A, Kes S (2000) P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23:1859–1862CrossRefPubMed Ozer N, Aytemir K, Atalar E, Sade E, Aksöyek S, Ovünç K, Açýl T, Nazlý N, Ozmen F, Oto A, Kes S (2000) P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23:1859–1862CrossRefPubMed
9.
Zurück zum Zitat Yazici M, Ozdemir K, Altunkeser BB, Kayrak M, Duzenli MA, Vatankulu MA, Soylu A, Ulgen MS (2007) The effect of diabetes mellitus on the P-wave dispersion. Circ J 71:880–883CrossRefPubMed Yazici M, Ozdemir K, Altunkeser BB, Kayrak M, Duzenli MA, Vatankulu MA, Soylu A, Ulgen MS (2007) The effect of diabetes mellitus on the P-wave dispersion. Circ J 71:880–883CrossRefPubMed
10.
Zurück zum Zitat Senen K, Turhan H, Riza Erbay A, Basar N, Saatci Yasar A, Sahin O, Yetkin E (2004) P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail 6:567–569CrossRefPubMed Senen K, Turhan H, Riza Erbay A, Basar N, Saatci Yasar A, Sahin O, Yetkin E (2004) P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail 6:567–569CrossRefPubMed
11.
Zurück zum Zitat Guray U, Guray Y, Yýlmaz MB, Mecit B, Sasmaz H, Korknaz S, Kutuk E (2003) Evaluation of P wave duration and P wave dispersion in adult patients with secundum atrial septal defect during normal sinus rhythm. Int J Cardiol 91:75–79CrossRefPubMed Guray U, Guray Y, Yýlmaz MB, Mecit B, Sasmaz H, Korknaz S, Kutuk E (2003) Evaluation of P wave duration and P wave dispersion in adult patients with secundum atrial septal defect during normal sinus rhythm. Int J Cardiol 91:75–79CrossRefPubMed
12.
Zurück zum Zitat Can I, Aytemir K, Demir AU, Deniz A, Ciftci O, Tokgozoglu L, Oto A, Sahin A (2009) P-wave duration and dispersion in patients with obstructive sleep apnea. Int J Cardiol 133:e85–e89CrossRefPubMed Can I, Aytemir K, Demir AU, Deniz A, Ciftci O, Tokgozoglu L, Oto A, Sahin A (2009) P-wave duration and dispersion in patients with obstructive sleep apnea. Int J Cardiol 133:e85–e89CrossRefPubMed
13.
Zurück zum Zitat Jazi MH, Amra B, Yazdchi MR, Jahangiri M, Tabesh F, Gholamrezaei A (2014) P wave duration and dispersion in Holter electrocardiography of patients with obstructive sleep apnea. Sleep Breath 18:549–554CrossRefPubMed Jazi MH, Amra B, Yazdchi MR, Jahangiri M, Tabesh F, Gholamrezaei A (2014) P wave duration and dispersion in Holter electrocardiography of patients with obstructive sleep apnea. Sleep Breath 18:549–554CrossRefPubMed
14.
Zurück zum Zitat Arat N, Kacar S, Golbasi Z, Akdogan M, Sokmen Y, Kuran S, Idilman R (2008) P wave dispersion is prolonged in patients with Wilson’s disease. World J Gastroenterol 14:1252–1256CrossRefPubMedPubMedCentral Arat N, Kacar S, Golbasi Z, Akdogan M, Sokmen Y, Kuran S, Idilman R (2008) P wave dispersion is prolonged in patients with Wilson’s disease. World J Gastroenterol 14:1252–1256CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Russo V, Rago A, Palladino A, Papa AA, Di Meo F, Della Cioppa N, Golino P, Russo MG, Calabrò R, Politano L, Nigro G (2011) P-wave duration and dispersion in patients with Emery–Dreifuss muscular dystrophy. J Investig Med 59:1151–1154CrossRefPubMed Russo V, Rago A, Palladino A, Papa AA, Di Meo F, Della Cioppa N, Golino P, Russo MG, Calabrò R, Politano L, Nigro G (2011) P-wave duration and dispersion in patients with Emery–Dreifuss muscular dystrophy. J Investig Med 59:1151–1154CrossRefPubMed
16.
Zurück zum Zitat Ozdemir O, Soylu M, Demir AD, Topaloglu S, Alyan O, Turhan H, Bicer A, Kutuk E (2004) P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy. Int J Cardiol 94(2–3):163–166 (Erratum in 97(3):581) CrossRefPubMed Ozdemir O, Soylu M, Demir AD, Topaloglu S, Alyan O, Turhan H, Bicer A, Kutuk E (2004) P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy. Int J Cardiol 94(2–3):163–166 (Erratum in 97(3):581) CrossRefPubMed
17.
Zurück zum Zitat Tükek T, Yildiz P, Akkaya V, Karan MA, Atilgan D, Yilmaz V, Korkut F (2002) Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann Noninvasive Electrocardiol 7:222–227CrossRefPubMed Tükek T, Yildiz P, Akkaya V, Karan MA, Atilgan D, Yilmaz V, Korkut F (2002) Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann Noninvasive Electrocardiol 7:222–227CrossRefPubMed
18.
Zurück zum Zitat Aras D, Maden O, Ozdemir O, Aras S, Topaloglu S, Yetkin E, Demir AD, Soylu MO, Erdogan MF, Kisacik HL, Korkmaz S (2005) Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism. Int J Cardiol 99:59–64CrossRefPubMed Aras D, Maden O, Ozdemir O, Aras S, Topaloglu S, Yetkin E, Demir AD, Soylu MO, Erdogan MF, Kisacik HL, Korkmaz S (2005) Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism. Int J Cardiol 99:59–64CrossRefPubMed
19.
Zurück zum Zitat Dogan U, Dogan EA, Tekinalp M, Tokgoz OS, Aribas A, Akilli H, Ozdemir K, Gok H, Yuruten B (2012) P-wave dispersion for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Med Sci 9:108–114CrossRefPubMed Dogan U, Dogan EA, Tekinalp M, Tokgoz OS, Aribas A, Akilli H, Ozdemir K, Gok H, Yuruten B (2012) P-wave dispersion for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Med Sci 9:108–114CrossRefPubMed
20.
Zurück zum Zitat Kato K, Ejima K, Fukushima N, Ishizawa M, Wakisaka O, Henmi R, Yoshida K, Nuki T, Arai K, Yashiro B, Manaka T, Ashihara K, Shoda M, Hagiwara N (2016) Catheter ablation of atrial fibrillation in patients with severely impaired left ventricular systolic function. Heart Vessels 31:584–592CrossRefPubMed Kato K, Ejima K, Fukushima N, Ishizawa M, Wakisaka O, Henmi R, Yoshida K, Nuki T, Arai K, Yashiro B, Manaka T, Ashihara K, Shoda M, Hagiwara N (2016) Catheter ablation of atrial fibrillation in patients with severely impaired left ventricular systolic function. Heart Vessels 31:584–592CrossRefPubMed
21.
Zurück zum Zitat Pang H, Ronderos R, Pérez-Riera AR, Femenía F, Baranchuk A (2011) Reverse atrial electrical remodeling: a systematic review. Cardiol J 18:625–631CrossRefPubMed Pang H, Ronderos R, Pérez-Riera AR, Femenía F, Baranchuk A (2011) Reverse atrial electrical remodeling: a systematic review. Cardiol J 18:625–631CrossRefPubMed
22.
Zurück zum Zitat Kishima H, Mine T, Takahashi S, Ashida K, Ishihara M, Masuyama T (2016) The impact of left atrial pressure on filtered P-wave duration in patients with atrial fibrillation. Heart Vessels 31:1848–1854CrossRefPubMed Kishima H, Mine T, Takahashi S, Ashida K, Ishihara M, Masuyama T (2016) The impact of left atrial pressure on filtered P-wave duration in patients with atrial fibrillation. Heart Vessels 31:1848–1854CrossRefPubMed
23.
Zurück zum Zitat Müller H, Noble S, Keller PF, Sigaud P, Gentil P, Lerch R, Shah D, Burri H (2008) Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-time three-dimensional echocardiography. Europace 10:1073–1078CrossRefPubMed Müller H, Noble S, Keller PF, Sigaud P, Gentil P, Lerch R, Shah D, Burri H (2008) Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-time three-dimensional echocardiography. Europace 10:1073–1078CrossRefPubMed
24.
Zurück zum Zitat Takahashi Y, Takahashi A, Kuwahara T, Okubo K, Fujino T, Takagi K, Nakashima E, Kamiishi T, Hikita H, Hirao K, Isobe M (2011) Renal function after catheter ablation of atrial fibrillation. Circulation 124:2380–2387CrossRefPubMed Takahashi Y, Takahashi A, Kuwahara T, Okubo K, Fujino T, Takagi K, Nakashima E, Kamiishi T, Hikita H, Hirao K, Isobe M (2011) Renal function after catheter ablation of atrial fibrillation. Circulation 124:2380–2387CrossRefPubMed
25.
Zurück zum Zitat Kurosaki K, Tada H, Hashimoto T, Ito S, Miyaji K, Naito S, Oshima S, Taniguchi K (2007) Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation. Circ J 71:313–320CrossRefPubMed Kurosaki K, Tada H, Hashimoto T, Ito S, Miyaji K, Naito S, Oshima S, Taniguchi K (2007) Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation. Circ J 71:313–320CrossRefPubMed
Metadaten
Titel
Noninvasive evaluation of reverse atrial remodeling after catheter ablation of atrial fibrillation by P wave dispersion
verfasst von
Yuhi Fujimoto
Kenji Yodogawa
Kenta Takahashi
Ippei Tsuboi
Hiroshi Hayashi
Shunsuke Uetake
Yu-ki Iwasaki
Meiso Hayashi
Yasushi Miyauchi
Wataru Shimizu
Publikationsdatum
19.06.2017
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 11/2017
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-017-1008-1

Weitere Artikel der Ausgabe 11/2017

Heart and Vessels 11/2017 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.